BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Emsellem HA, Thorpy MJ, Lammers GJ, Shapiro CM, Mayer G, Plazzi G, Chen D, Carter LP, Villa KF, Lee L, Menno D, Black J, Dauvilliers Y. Measures of functional outcomes, work productivity, and quality of life from a randomized, phase 3 study of solriamfetol in participants with narcolepsy. Sleep Medicine 2020;67:128-36. [DOI: 10.1016/j.sleep.2019.11.1250] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhang W, Tocher P, L'Heureux J, Sou J, Sun H. Measuring, Analyzing, and Presenting Work Productivity Loss in Randomized Controlled Trials: A Scoping Review. Value Health 2022:S1098-3015(22)02070-8. [PMID: 35961865 DOI: 10.1016/j.jval.2022.06.015] [Reference Citation Analysis]
2 Ishikawa O, Hahn S, Greenberg H; Northwell Sleep Disorders Centre, Division of Pulmonary, Critical Care and Sleep Medicine, Donald and Barbara Zucker School of Medicine, Hofstra-Northwell, Northwell Health, NY, USA, Northwell Sleep Disorders Centre, Division of Pulmonary, Critical Care and Sleep Medicine, Donald and Barbara Zucker School of Medicine, Hofstra-Northwell, Northwell Health, NY, USA, Northwell Sleep Disorders Centre, Division of Pulmonary, Critical Care and Sleep Medicine, Donald and Barbara Zucker School of Medicine, Hofstra-Northwell, Northwell Health, NY, USA. Pharmacologic Therapy for Narcolepsy. Neurology 2022;18:68. [DOI: 10.17925/usn.2022.18.1.68] [Reference Citation Analysis]
3 Weaver TE, Pepin JL, Schwab R, Shapiro C, Hedner J, Ahmed M, Foldvary-Schaefer N, Strollo PJ, Mayer G, Sarmiento K, Baladi M, Bron M, Chandler P, Lee L, Malhotra A. Long-term effects of solriamfetol on quality of life and work productivity in participants with excessive daytime sleepiness associated with narcolepsy or obstructive sleep apnea. J Clin Sleep Med 2021;17:1995-2007. [PMID: 34606437 DOI: 10.5664/jcsm.9384] [Reference Citation Analysis]
4 Maski K, Trotti LM, Kotagal S, Robert Auger R, Swick TJ, Rowley JA, Hashmi SD, Watson NF. Treatment of central disorders of hypersomnolence: an American Academy of Sleep Medicine systematic review, meta-analysis, and GRADE assessment. J Clin Sleep Med 2021;17:1895-945. [PMID: 34743790 DOI: 10.5664/jcsm.9326] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
5 Thorpy MJ, Ohayon MM, Carls G, Black J, Pasta DJ, Hyman DL, Villa KF. Assessing the impact of sodium oxybate treatment on functioning, productivity, and health-related quality of life in patients with narcolepsy: findings from the Nexus Narcolepsy Registry (waves 1-4). Sleep Med 2021;84:380-8. [PMID: 34247126 DOI: 10.1016/j.sleep.2021.06.010] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Tadrous R, O'Rourke D, Mockler D, Broderick J. Health-related quality of life in narcolepsy: A systematic review and meta-analysis. J Sleep Res 2021;:e13383. [PMID: 34036640 DOI: 10.1111/jsr.13383] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
7 Cuomo MC, Sheehan AH, Jordan JK. Solriamfetol for the Management of Excessive Daytime Sleepiness. J Pharm Pract 2021;:8971900211009080. [PMID: 33882756 DOI: 10.1177/08971900211009080] [Reference Citation Analysis]
8 Gnanasakthy A, Barrett A, Norcross L, D'Alessio D, Romano CD. Use of Patient and Investigator Global Impression Scales: A Review of Food and Drug Administration-Approved Labeling, 2009 to 2019. Value Health 2021;24:1016-23. [PMID: 34243825 DOI: 10.1016/j.jval.2021.01.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Abad VC. Profile of Solriamfetol in the Management of Excessive Daytime Sleepiness Associated with Narcolepsy or Obstructive Sleep Apnea: Focus on Patient Selection and Perspectives. Nat Sci Sleep 2021;13:75-91. [PMID: 33531850 DOI: 10.2147/NSS.S245020] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 11.0] [Reference Citation Analysis]
10 Subedi R, Singh R, Thakur RK, K C B, Jha D, Ray BK. Efficacy and safety of solriamfetol for excessive daytime sleepiness in narcolepsy and obstructive sleep apnea: a systematic review and meta-analysis of clinical trials. Sleep Med 2020;75:510-21. [PMID: 33032062 DOI: 10.1016/j.sleep.2020.09.019] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
11 Kim H, Cho JW. Narcolepsy, How do We Manage it? J Sleep Med 2020;17:1-10. [DOI: 10.13078/jsm.200006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
12 Powell J, Piszczatoski C, Garland S. Solriamfetol for Excessive Sleepiness in Narcolepsy and Obstructive Sleep Apnea. Ann Pharmacother 2020;54:1016-20. [PMID: 32270686 DOI: 10.1177/1060028020915537] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]